Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eton Pharmaceuticals (ETON) Assets Average (2019 - 2025)

Eton Pharmaceuticals' Assets Average history spans 7 years, with the latest figure at $103.1 million for Q3 2025.

  • For Q3 2025, Assets Average rose 204.72% year-over-year to $103.1 million; the TTM value through Sep 2025 reached $103.1 million, up 204.72%, while the annual FY2024 figure was $53.9 million, 90.0% up from the prior year.
  • Assets Average for Q3 2025 was $103.1 million at Eton Pharmaceuticals, up from $92.9 million in the prior quarter.
  • Across five years, Assets Average topped out at $103.1 million in Q3 2025 and bottomed at $22.3 million in Q3 2022.
  • The 5-year median for Assets Average is $30.5 million (2021), against an average of $39.6 million.
  • The largest annual shift saw Assets Average dropped 24.31% in 2022 before it skyrocketed 204.72% in 2025.
  • A 5-year view of Assets Average shows it stood at $27.0 million in 2021, then dropped by 13.91% to $23.3 million in 2022, then soared by 35.91% to $31.6 million in 2023, then surged by 76.97% to $56.0 million in 2024, then skyrocketed by 84.15% to $103.1 million in 2025.
  • Per Business Quant, the three most recent readings for ETON's Assets Average are $103.1 million (Q3 2025), $92.9 million (Q2 2025), and $80.1 million (Q1 2025).